Effects of liraglutide on gallbladder emptying: A randomized, placebo‐controlled trial in adults with overweight or obesity

AIMS: Treatment with liraglutide 3.0 mg has been associated with gallbladder‐related adverse events. To conduct a single‐centre, double‐blind, 12‐week trial comparing the effect of 0.6 mg liraglutide and steady‐state liraglutide 3.0 mg with placebo on gallbladder emptying in adults with body mass in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Diabetes Obes Metab
Autores principales: Nexøe‐Larsen, Christina C., Sørensen, Pernille H., Hausner, Helene, Agersnap, Mikkel, Baekdal, Mille, Brønden, Andreas, Gustafsson, Lea N., Sonne, David P., Vedtofte, Louise, Vilsbøll, Tina, Knop, Filip K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220792/
https://ncbi.nlm.nih.gov/pubmed/29892986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13420
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares